17-HYDROXYPROGESTERONE (17-OHP) - ANVISA Registration 10338930242

Access comprehensive regulatory information for 17-HYDROXYPROGESTERONE (17-OHP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10338930242 and manufactured by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAMETRA SRL, DRG INSTRUMENTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.